Kazia Therapeutics
KZIA
11 hedge funds and large institutions have $2.31M invested in Kazia Therapeutics in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
220% more capital invested
Capital invested by funds: $723K → $2.31M (+$1.59M)
38% more funds holding
Funds holding: 8 → 11 (+3)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Truist Financial
Charlotte,
North Carolina
|
+$364K |
| 2 |
Morgan Stanley
New York
|
+$260K |
| 3 |
Renaissance Technologies
New York
|
+$64.8K |
| 4 |
HAG
HighPoint Advisor Group
Downers Grove,
Illinois
|
+$33.8K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$11.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SPIA
Steward Partners Investment Advisory
New York
|
-$1.41K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $1.02M | +$260K | +924 | +44% |
|
|
2
Renaissance Technologies
New York
| $523K | +$64.8K | +230 | +17% |
|
|
3
Truist Financial
Charlotte,
North Carolina
| $436K | +$364K | +1,292 | New |
|
|
HAG
4
HighPoint Advisor Group
Downers Grove,
Illinois
| $230K | +$33.8K | +120 | +18% |
|
|
TW
5
Transform Wealth
Greenwood Village,
Colorado
| $77K | – | – | – |
|
|
6
Wells Fargo
San Francisco,
California
| $14K | +$11.3K | +40 | New |
|
7
UBS Group
Zurich,
Switzerland
| $9K | +$6.76K | +24 | +1,200% |
|
8
Acadian Asset Management
Boston,
Massachusetts
| $6K | +$5.35K | +19 | New |
|
|
SPIA
9
Steward Partners Investment Advisory
New York
| $1K | -$1.41K | -5 | -71% |
|
|
RE
10
RBC Europe
London,
United Kingdom
| $216 | – | – | – |
|
KZIA Hedge Fund Activity: Q3 2020 in Review
11 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q3 2020, worth a combined $2.31M — up 220% from $723K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new KZIA positions and 0 closed out — a net gain of 3 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Truist Financial, opening a new position worth an estimated $364K. The largest seller was Steward Partners Investment Advisory, cutting an estimated $1.41K.
- 11 institutional investors held Kazia Therapeutics (KZIA) as of Q3 2020, up from 8 in Q2 2020.
- Funds reported $2.31M of Kazia Therapeutics stock for Q3 2020, up 220% quarter-over-quarter.
- 3 funds opened new Kazia Therapeutics positions in Q3 2020 and 0 closed out, a net change of +3 holders.
- The largest Kazia Therapeutics buyer in Q3 2020 was Truist Financial, an estimated $364K added.
- The largest Kazia Therapeutics seller in Q3 2020 was Steward Partners Investment Advisory, an estimated $1.41K sold.
Based on aggregated 13F filings for Q3 2020.